Pliant Therapeutics Growth Metrics (2020-2025) | PLRX

Growth Metrics Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Growth Ratios
EBITDA Margin Growth (1y) -0.11M-0.08M-0.13M-0.08M-0.13M0.07M-0.05M-0.05M-0.05M-1.64M
EBITDA Margin Growth (3y) -0.28M-1.65M0.94M0.60M0.54M
EBITDA Margin Growth (5y) 0.70M0.58M0.36M
EBITDA Margin (QoQ) -0.05M0.01M-0.01M-0.06M-0.02M-0.04M0.04M-0.11M0.17M-0.15M0.04M-0.10M-1.42M-0.17M-0.21M
EBIT Margin Growth (1y) -0.11M-0.08M-0.13M-0.08M-0.12M0.07M-0.05M-0.07M-0.09M-1.85M
EBIT Margin Growth (3y) -0.32M-1.86M0.96M0.62M0.56M
EBIT Margin Growth (5y) 0.73M0.61M0.38M
EBIT Margin (QoQ) -0.05M0.01M-0.01M-0.06M-0.02M-0.04M0.05M-0.10M0.17M-0.16M0.03M-0.13M-1.59M-0.17M-0.22M
EBT Margin Growth (1y) -0.11M-0.08M-0.13M-0.08M-0.12M0.07M-0.04M-0.06M-0.06M-1.60M
EBT Margin Growth (3y) -0.29M-1.61M0.93M0.59M0.53M
EBT Margin Growth (5y) 0.70M0.58M0.36M
EBT Margin (QoQ) -0.05M0.01M-0.01M-0.06M-0.02M-0.04M0.05M-0.10M0.17M-0.15M0.03M-0.10M-1.38M-0.17M-0.21M
Enterprise Value Growth (1y) -169.42%21.92%24.81%27.55%32.50%32.95%-62.97%-65.10%-223.82%-239.35%-45.35%-49.23%16.44%21.35%22.75%28.03%36.64%39.79%40.23%
Enterprise Value Growth (3y) -47.71%-21.12%-21.21%-21.30%-22.24%-21.41%-22.32%-21.04%-19.68%-17.13%12.44%
Enterprise Value Growth (5y) -28.19%3.40%3.83%
Enterprise Value (QoQ) 5.91%5.82%4.62%7.62%9.40%9.25%11.12%8.24%-120.20%8.07%-74.32%3.84%5.68%5.61%2.40%9.49%7.35%12.06%14.08%13.99%8.02%
FCF Margin Growth (1y) -0.06M-0.13M-0.11M-0.06M-0.11M0.06M0.01M-0.06M-0.06M-0.97M
FCF Margin Growth (3y) -0.22M-1.04M0.78M0.55M0.39M
FCF Margin Growth (5y) 0.62M0.48M0.29M
FCF Margin (QoQ) 0.03M-0.05M-0.01M-0.03M-0.05M-0.03M0.04M-0.07M0.12M-0.08M-0.03M-0.07M-0.79M-0.11M-0.24M
Interest Coverage Ratio Growth (1y) 13.41%-41.73%-24.20%13.02%52.91%52.99%56.37%37.35%19.33%50.95%
Interest Coverage Ratio Growth (3y) 30.97%31.12%
Interest Coverage Ratio (QoQ) 38.06%-11.16%-14.72%-9.61%-1.39%2.59%19.65%40.66%-1.22%9.59%-15.37%23.60%38.45%
Net Margin Growth (1y) -0.08M-0.13M-0.08M-0.12M0.07M-0.04M-0.06M-0.06M-1.60M
Net Margin Growth (3y) -1.61M0.93M0.59M0.53M
Net Margin Growth (5y) 0.58M0.36M
Net Margin (QoQ) 0.01M-0.01M-0.06M-0.02M-0.04M0.05M-0.10M0.17M-0.15M0.03M-0.10M-1.38M-0.17M-0.21M
Operating Margin Growth (1y) -0.11M-0.08M-0.13M-0.08M-0.12M0.07M-0.05M-0.07M-0.09M-1.85M
Operating Margin Growth (3y) -0.32M-1.86M0.96M0.62M0.56M
Operating Margin Growth (5y) 0.73M0.61M0.38M
Operating Margin (QoQ) -0.05M0.01M-0.01M-0.06M-0.02M-0.04M0.05M-0.10M0.17M-0.16M0.03M-0.13M-1.59M-0.17M-0.22M
Return on Assets Growth (1y) -30.00-29.00-23.00-27.00-3.009.0021.0033.0012.003.00-5.00-12.00-16.00-19.00-26.00-27.00-17.00
Return on Assets Growth (3y) -21.00-17.00-7.00-6.00-6.00-7.00-10.00-7.00-21.00
Return on Assets Growth (5y) -54.00
Return on Assets (QoQ) -7.00-13.00-4.00-7.00-5.00-6.00-8.0017.006.006.003.00-3.00-3.00-2.00-4.00-7.00-7.00-9.00-5.003.00
Return on Capital Employed Growth (1y) -32.00-26.00-33.00-5.009.0023.0037.0012.000.00M-9.00-16.00-19.00-22.00-29.00-29.00-16.00
Return on Capital Employed Growth (3y) -23.00-13.00-12.00-13.00-13.00-15.00-8.00-24.00
Return on Capital Employed (QoQ) -13.00-5.00-8.00-7.00-8.00-11.0020.007.006.003.00-4.00-4.00-3.00-4.00-8.00-7.00-10.00-4.004.00
Return on Equity Growth (1y) -32.00-32.00-27.00-36.00-7.008.0025.0042.0017.005.00-7.00-18.00-25.00-32.00-41.00-42.00-29.00
Return on Equity Growth (3y) -23.00-19.00-10.00-13.00-15.00-18.00-23.00-19.00-37.00
Return on Equity Growth (5y) -76.00
Return on Equity (QoQ) -7.00-13.00-4.00-8.00-7.00-9.00-13.0021.009.008.004.00-4.00-3.00-4.00-7.00-10.00-10.00-14.00-9.003.00
Return on Sales Growth (1y) -0.00M-804.00-0.00M-796.00-0.00M684.00-386.00-557.00-569.00-0.02M-0.00M-0.01M-0.07M0.08M
Return on Sales Growth (3y) -0.00M-0.02M-0.00M-0.01M-0.07M0.01M0.01M0.01M
Return on Sales Growth (5y) 0.01M0.01M0.00M
Return on Sales (QoQ) -510.00129.00-87.00-621.00-225.00-404.00453.00-0.00M0.00M-0.00M282.00-0.00M-0.01M0.01M-0.01M-0.06M-0.00M-0.00M